Mainz Biomed Reports Results of 2024 Annual General Meeting
GlobeNewswire
BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics..
BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics..
PRESS RELEASE - 06/05/2024, 07:00 CEST
*Biocartis and Merck to Collaborate on Improving Patient Access to Personalized..
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global DNA Methylation Detection Technology Market: Focus on Technology,..